Syphilis Treatment Among People Who Are Pregnant in Six U.S. States, 2018-2021.
| Title: | Syphilis Treatment Among People Who Are Pregnant in Six U.S. States, 2018-2021. |
|---|---|
| Authors: | Tannis A; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, and the Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, and the Georgia Department of Public Health, Atlanta, Georgia; Eagle Global Scientific, LLC, San Antonio, Texas; Lukos LLC, Tampa, Florida; the Arizona Department of Health Services and Maricopa County Public Health, Phoenix, Arizona; the New Jersey Department of Health, Trenton, New Jersey; the Washington State Department of Health, Bellevue, Washington; and the New York State Department of Health, Albany, New York.; Miele K; Carlson JM; O'Callaghan KP; Woodworth KR; Anderson B; Praag A; Pulliam K; Coppola N; Willabus T; Mbotha D; Abetew D; Currenti S; Longcore ND; Akosa A; Meaney-Delman D; Tong VT; Gilboa SM; Olsen EO |
| Source: | Obstetrics and gynecology [Obstet Gynecol] 2024 Jun 01; Vol. 143 (6), pp. 718-729. Date of Electronic Publication: 2024 Apr 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Language: | English |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401101 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-233X (Electronic) Linking ISSN: 00297844 NLM ISO Abbreviation: Obstet Gynecol Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2004- : Hagerstown, MD : Lippincott Williams & Wilkins; Original Publication: New York. |
| MeSH Terms: | Syphilis*/epidemiology ; Syphilis*/diagnosis ; Syphilis*/drug therapy ; Pregnancy Complications, Infectious*/drug therapy ; Pregnancy Complications, Infectious*/epidemiology ; Prenatal Care*; United States/epidemiology ; Syphilis, Congenital/prevention & control ; Syphilis, Congenital/epidemiology ; Syphilis, Congenital/drug therapy ; Anti-Bacterial Agents/therapeutic use ; Humans ; Female ; Pregnancy ; Adult ; Young Adult ; Adolescent |
| Abstract: | Objective: To describe syphilis treatment status and prenatal care among people with syphilis during pregnancy to identify missed opportunities for preventing congenital syphilis.; Methods: Six jurisdictions that participated in SET-NET (Surveillance for Emerging Threats to Pregnant People and Infants Network) conducted enhanced surveillance among people with syphilis during pregnancy based on case investigations, medical records, and linkage of laboratory data with vital records. Unadjusted risk ratios (RRs) were used to compare demographic and clinical characteristics by syphilis stage (primary, secondary, or early latent vs late latent or unknown) and treatment status during pregnancy (adequate per the Centers for Disease Control and Prevention's "Sexually Transmitted Infections Treatment Guidelines, 2021" vs inadequate or not treated) and by prenatal care (timely: at least 30 days before pregnancy outcome; nontimely: less than 30 days before pregnancy outcome; and no prenatal care).; Results: As of September 15, 2023, of 1,476 people with syphilis during pregnancy, 855 (57.9%) were adequately treated and 621 (42.1%) were inadequately treated or not treated. Eighty-two percent of the cohort received timely prenatal care. Although those with nontimely or no prenatal care were more likely to receive inadequate or no treatment (RR 2.50, 95% CI, 2.17-2.88 and RR 2.73, 95% CI, 2.47-3.02, respectively), 32.1% of those with timely prenatal care were inadequately or not treated. Those with reported substance use or a history of homelessness were nearly twice as likely to receive inadequate or no treatment (RR 2.04, 95% CI, 1.82-2.28 and RR 1.83, 95% CI, 1.58-2.13, respectively).; Conclusion: In this surveillance cohort, people without timely prenatal care had the highest risk for syphilis treatment inadequacy; however, almost a third of people who received timely prenatal care were not adequately treated. These findings underscore gaps in syphilis screening and treatment for pregnant people, especially those experiencing substance use and homelessness, and the need for systems-based interventions, such as treatment outside of traditional prenatal care settings.; (Copyright © 2024 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.) |
| Competing Interests: | Financial Disclosure The authors did not report any potential conflicts of interest. |
| References: | Eppes CS, Stafford I, Rac M. Syphilis in pregnancy: an ongoing public health threat. Am J Obstet Gynecol 2022;227:822–38. doi: 10.1016/j.ajog.2022.07.041. (PMID: 10.1016/j.ajog.2022.07.041); Hook EW. Syphilis. Lancet 2017;389:1550–7. doi: 10.1016/s0140-6736(16)32411-4. (PMID: 10.1016/s0140-6736(16)32411-4); Cooper JM, Sánchez PJ. Congenital syphilis. Semin Perinatol 2018;42:176–84. doi: 10.1053/j.semperi.2018.02.005. (PMID: 10.1053/j.semperi.2018.02.005); Tsimis ME, Sheffield JS. Update on syphilis and pregnancy. Birth Defects Research 2017;109:347–52. doi: 10.1002/bdra.23562. (PMID: 10.1002/bdra.23562); Centers for Disease Control and Prevention. Sexually transmitted infections surveillance, 2022. Accessed February 15, 2024. https://www.cdc.gov/std/statistics/2022/.; Centers for Disease Control and Prevention. U.S. STI epidemic showed no signs of slowing in 2021 – cases continued to escalate. Accessed February 15, 2024. https://www.cdc.gov/media/releases/2023/s0411-sti.html.; Centers for Disease Control and Prevention. State statutory and regulatory language regarding prenatal syphilis screenings in the United States. Accessed June 12, 2023. https://www.cdc.gov/std/treatment/syphilis-screenings.htm.; US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for syphilis infection in pregnant women: US preventive services task force reaffirmation recommendation statement. JAMA 2018;320:911–7. doi: 10.1001/jama.2018.11785. (PMID: 10.1001/jama.2018.11785); Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021;70:1–187. doi: 10.15585/mmwr.rr7004a1. (PMID: 10.15585/mmwr.rr7004a1); McDonald R, O'Callaghan K, Torrone E, Barbee L, Grey J, Jackson D, et al. Vital signs: missed opportunities for preventing congenital syphilis — United States, 2022. MMWR Morb Mortal Wkly Rep 2023;72:1269–74. doi: 10.15585/mmwr.mm7246e1. (PMID: 10.15585/mmwr.mm7246e1); Woodworth KR, Reynolds MR, Burkel V, Gates C, Eckert V, McDermott C, et al. A preparedness model for mother-baby linked longitudinal surveillance for emerging threats. Matern Child Health J 2021;25:198–206. doi: 10.1007/s10995-020-03106-y. (PMID: 10.1007/s10995-020-03106-y); Centers for Disease Control and Prevention. Syphilis, congenital 2018 case definition. Accessed June 12, 2023. https://ndc.services.cdc.gov/case-definitions/syphilis-congenital-2018/.; U.S. Department of Health & Human Services. Congenital syphilis case investigation and reporting form instructions. Accessed November 30, 2023. https://www.cdc.gov/std/program/ConSyphReporting-Instructions7-10-2014.pdf.; Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64:1–137.; Kimball A, Torrone E, Miele K, Bachmann L, Thorpe P, Weinstock H, et al. Missed opportunities for prevention of congenital syphilis - United States, 2018. MMWR Morb Mortal Wkly Rep 2020;69:661–5. doi: 10.15585/mmwr.mm6922a1. (PMID: 10.15585/mmwr.mm6922a1); Martin EG, Ansari B, Rosenberg ES, Hart-Malloy R, Smith D, Bernstein KT, et al. Variation in patterns of racial and ethnic disparities in primary and secondary syphilis diagnosis rates among heterosexually active women by region and age group in the United States. Sex Transm Dis 2022;49:330–7. doi: 10.1097/olq.0000000000001607. (PMID: 10.1097/olq.0000000000001607); Chan EYL, Smullin C, Clavijo S, Papp-Green M, Park E, Nelson M, et al. A qualitative assessment of structural barriers to prenatal care and congenital syphilis prevention in Kern County, California. PLoS One 2021;16:e0249419. doi: 10.1371/journal.pone.0249419. (PMID: 10.1371/journal.pone.0249419); Harville EW, Giarratano GP, Buekens P, Lang E, Wagman J. Congenital syphilis in East Baton Rouge parish, Louisiana: providers' and women's perspectives. BMC Infect Dis 2021;21:64. doi: 10.1186/s12879-020-05753-6. (PMID: 10.1186/s12879-020-05753-6); Kroeger KA, Sangaramoorthy T, Loosier PS, Schmidt R, Gruber D. Pathways to congenital syphilis prevention: a rapid qualitative assessment of barriers, and the public health response, in Caddo Parish, Louisiana. Sex Transm Dis 2018;45:442–6. doi: 10.1097/olq.0000000000000787. (PMID: 10.1097/olq.0000000000000787); Barfield WD, Besera G, Cox S, Warner L, Azeez O, Riggs J, et al. From data to action: CDC's public health surveillance for women, infants, and children. Accessed November 30, 2023. https://www.cdc.gov/reproductivehealth/productspubs/data-to-action-e-book/index.htm#:∼:text=This%20updated%20monograph%20offers%20health,the%20health%20of%20these%20populations.; Fryer K, Delgado A, Foti T, Reid CN, Marshall J. Implementation of obstetric telehealth during COVID-19 and beyond. Matern Child Health J 2020;24:1104–10. doi: 10.1007/s10995-020-02967-7. (PMID: 10.1007/s10995-020-02967-7); Khoury JE, Atkinson L, Bennett T, Jack SM, Gonzalez A. Prenatal distress, access to services, and birth outcomes during the COVID-19 pandemic: findings from a longitudinal study. Early Hum Dev 2022;170:105606. doi: 10.1016/j.earlhumdev.2022.105606. (PMID: 10.1016/j.earlhumdev.2022.105606); Nurse-Findlay S, Taylor MM, Savage M, Mello MB, Saliyou S, Lavayen M, et al. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: an evaluation from multi-country surveys and stakeholder interviews. PLoS Med 2017;14:e1002473. doi: doi: 10.1371/journal.pmed.1002473. (PMID: 10.1371/journal.pmed.1002473); Ingram DD, Franco SJ. 2013 NCHS Urban-Rural Classification Scheme for Counties. Vital Health Statistics Ser 2014;2:1–73. |
| Grant Information: | CC999999 United States ImCDC Intramural CDC HHS |
| Substance Nomenclature: | 0 (Anti-Bacterial Agents) |
| Entry Date(s): | Date Created: 20240416 Date Completed: 20240516 Latest Revision: 20260423 |
| Update Code: | 20260423 |
| PubMed Central ID: | PMC11337980 |
| DOI: | 10.1097/AOG.0000000000005586 |
| PMID: | 38626449 |
| Database: | MEDLINE |
Journal Article; Research Support, Non-U.S. Gov't